首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引36446
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Suqin Hu,Yanan Guo,Mingyan Li et al. Suqin Hu et al.
Introduction: Autophagy can either support cell survival or promote cell death in response to therapeutic stress, yet the molecular switch that determines this directionality remains poorly defined. ...
Jessica S Zhang,Juliana C K Ng,Pedro Hermida de Viveiros et al. Jessica S Zhang et al.
Metastatic soft tissue sarcomas (STSs) are a heterogeneous group of rare mesenchymal tumors whose treatment options are limited. Our group has been interested in utilizing the synthetic toll-like receptor 4 (TLR4) agonist, glycopyranosyl li...
Zhiqiang Zeng,Xionglin Hu,Tao Zhou et al. Zhiqiang Zeng et al.
Objective: Does the simplified PADUA renal (SPARE) nephrometry system predict perioperative outcomes after partial nephrectomy (PN)? Methods: ...
Jingjing Xie,Kaihe Lin,Suying Wu et al. Jingjing Xie et al.
Background: Accurate prediction of pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) for rectal cancer is crucial for determining subsequent treatment strategies. Although studies have shown ...
Juan Bu,Yeledan Mahan,Reziwanguli Yuemaier et al. Juan Bu et al.
Imatinib, a tyrosine kinase inhibitor, is primarily used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors (GIST). The most common adverse events include peripheral edema, mild nausea, vomiting, diarrhea, mya...
Jiaoya Lin,Xin Zhang,Yifei Zhao et al. Jiaoya Lin et al.
Introduction: Multiple myeloma (MM) is the second most common hematological malignancy, characterized by the abnormal proliferation of malignant plasma cells leading to the classic CRAB symptoms. Despite advances in treat...
Faxian Gao,Yijun Fan,Qingchun Fan et al. Faxian Gao et al.
Background: Precision therapy for non-small cell lung cancer (NSCLC) has expanded to include rare driver genes. RET fusion is a rare target in lung cancer, and data on targeted therapy combined with local consolidation su...
Min Zhang,Yu Rong Ma,Xuan Yu Chen et al. Min Zhang et al.
MicroRNA-17(miR-17) is a prototypical oncogenic miRNA that plays a central driving role in the initiation and progression of various malignant tumours (MT), including lymphoma, lung cancer, colorectal cancer (CRC), and breast cancer (BC). I...
Chen Li,Yuka Yanase,Ming-Quan Pang Chen Li
Synthesizing recent literature from 2025 to 2026, this mini-review critically evaluates the methodological evolution of artificial intelligence (AI) in hepatocellular carcinoma (HCC) from static pattern recognition to mechanism-driven spati...